[A case of hepatocellular carcinoma in an elderly patient that improved upon combination therapy of Lentinan and Tegafur]

Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 1):1517-9.
[Article in Japanese]

Abstract

The case was an 83-year-old man whose chief complaint was right-hypochondralgia and high fever. His laboratory findings at the first visit revealed liver dysfunction and an elevation of AFP level. Abdominal ultra-sonography revealed a giant tumor in his liver. Because of his advanced age and the large size of his tumor, he was given 2 mg Lentinan a week and 750 mg Tegafur every day. After 3 months his serum AFP level decreased to normal range, and on computed tomography his tumor disappeared completely 6 months after the beginning of this therapy. We recommend the combination therapy of Lentinan and Tegafur for patients with a high risk for usual therapies like this case for their quality of life.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Hepatocellular / blood
  • Carcinoma, Hepatocellular / drug therapy*
  • Humans
  • Lentinan / administration & dosage
  • Liver Neoplasms / blood
  • Liver Neoplasms / drug therapy*
  • Male
  • Remission Induction
  • Tegafur / administration & dosage
  • alpha-Fetoproteins / metabolism

Substances

  • alpha-Fetoproteins
  • Tegafur
  • Lentinan